Back to search

Netherlands· NL-716a145ec8bd

Sunmedabon, Combinatieverpakking mifepriston 200 mg tablet en misoprostol 4 x 0,2 mg vaginale tabletten

A misoprostol product containing mifepriston + misoprostol, registered in Netherlands by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC G02AD06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSunmedabon, Combinatieverpakking mife…ATCG02AD06REGISTER NO.NL-716a145ec8bdPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Misoprostol is registered in 11 of 19 countries.

Countries holding a registration under ATC G02AD06 (misoprostol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Misoprostol · ATC G02AD06

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of misoprostol costs, country by country.

Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Misoprostol · price per daily dose (0.2 mg)

USD · FX 28 Sept 2026

  • US United States$0.72 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MIFEPRISTON + MISOPROSTOL
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Country
Netherlands (NL)
ATC code
G02AD06
ATC class
Misoprostol
Defined daily dose
0.2 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    106099

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

245 interactions on record for misoprostol.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Misoprostol · interactions on record

245 records

  • 10 moderate
  • 6 minor
  • 229 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Misoprostol in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All misoprostol products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Medabon Combipack
  • Romania · Medabon Pachet Combinat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/afb91418-aed9-4d2f-8baf-d5e4e4b8a19f
GET /v1/drugs/afb91418-aed9-4d2f-8baf-d5e4e4b8a19f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik, Vaginaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h106099_smpc.pdf",
  "strength": null,
  "atc_label": "Misoprostol#G03XB51 - Mifepristone, combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg106099",
  "excipients": [
    "CASTOROLIE, GEHYDROGENEERD",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "MIFEPRISTON",
    "MISOPROSTOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h106099.pdf",
  "authorised_at": "2012/05/09",
  "procedure_number": "NL/H/4796/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "106099",
  "additional_monitoring": "N"
}

See everything about misoprostol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.